The global spectral computed tomography (CT) market is characterized by the presence of global, regional, and local vendors. The market is highly competitive with all players competing to gain market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, quality, and reliability. It is decisive for the vendors to provide cost-efficient and high-quality products, to survive and succeed in an intensely competitive and growing market environment.
The growth of market vendors is dependent on market conditions, government support, and industry development. Thus, vendors should focus on expanding geographically and improving their products. They primarily focus on the development of novel products. Although international players are dominating the market, regional, and foreign players with small market shares also have a presence. The international players may strengthen their presence worldwide through acquisitions during the forecast period. It has also been forecast that improvement of the global economic scenario combined with efforts to enhance infrastructure in emerging nations, is fueling the market growth, thereby making it an ideal time for new products and to increase the global market share. Vendors with better technical and financial resources could develop innovative products. Therefore, vendors must develop new technologies and stay abreast of emerging technologies that could affect the continuing competitiveness of their treatment lines in the market.
General Electric Company (GE) is the parent company of GE Healthcare. GE Healthcare is a leading provider of medical imaging, monitoring, bio-manufacturing, and cell and gene therapy technologies and holds a significant position in the market. The company enables precision health in diagnostics, therapeutics, and monitoring through intelligent devices, data analytics, applications, and services. It has over 100 years of experience in the healthcare industry and helps improve outcomes more efficiently for patients, healthcare providers, researchers, and life science companies around the world. It has over four million imaging, mobile diagnostic, and monitoring units installed globally.
Bargaining Power of Suppliers
The suppliers in the global spectral computed tomography (CT) market are manufacturers of diagnostic imaging devices and technology platform developers. There are few suppliers present in the global spectral computed tomography (CT) market. Switching cost of these suppliers is high due to the high level of differentiation in intense competition. Additionally, research and development cost required for the development of software is quite high. Moreover, suppliers are likely to enter into long term partnerships with the healthcare providers and involved in more than one projects with the same client. Due to the increasing demand for cost-effective and efficient spectral computed tomography (CT), major companies are focusing on the emerging markets, due to the availability of a large number of customers.
Moreover, a smaller number of suppliers are there to cater to the needs of the customers, which lead to intense competition between the existing suppliers. However, the development of easy to use the software is a tough task, and software should provide accurate information regarding diagnosis. Hence, healthcare providers are selective about suppliers. Due to this, the overall bargaining power of suppliers in the global spectral computed tomography (CT) market is moderate to high.
Bargaining Power of Buyers
The bargaining power of buyers is moderate in the global spectral computed tomography (CT) market. The market has many buyers and a limited number of spectral computed tomography (CT) providers to cater to the need of the buyers. However, spectral computed tomography (CT) is specialized and play an important role in healthcare services management, and the buyers of the spectral computed tomography (CT) are moderately inclined towards quality platforms developed by trusted companies. As the technology platforms and software are used for diagnosis purpose and highly specialized; hence, limited client substitutes are available in the market. Also, most of the buyers are healthcare providers, and they are likely to enter into the long-term agreements with the spectral computed tomography (CT) manufacturers for uninterrupted service. Moreover, they can exert pressure on the manufacturers due to the intense rivalry in the market, which is responsible for the increased bargaining power of buyers.
Threat of New Entrants
The threat of new entrants is moderate in the global spectral computed tomography (CT) market. Any company trying to develop diagnostic imaging devices is required to accept or abide by the mandatory regulatory standards. However, the budget required for the development of the diagnostic imaging devices platform is high as compared to other industries. Diagnostic imaging devices are specialized and developed to be used for the collection and sharing of patient data with ease. Moreover, the majority of the customers are using technology platforms developed by trusted providers, and they are likely to prefer established brands over new market player due to quality concerns and to maintain the quality of the final product, which does not comfort the new entrants to enter the market easily.
Threat of Substitutes
The threat of substitutes in the global spectral computed tomography (CT) market is moderate to high. Diagnostic imaging devices play an important role in the systematic gathering of data from different sources. There are several options available in the market to serve the need of the customers and which are responsible for increasing the threat of substitute. Many companies are developing systems which are compatible with different modalities and applications.
Additionally, the increasing research and development activities and demand for efficient technology platforms are likely to provide new substitutes to the medical image management. Also, the high degree of customization decreases the threat of substitutes. The overall threat of substitutes in the global diagnostic imaging devices is moderate to high.
Intensity of Rivalry
The rivalry in the global spectral computed tomography (CT) market is moderate to high. The limited number of customers and product launches by major players increases the intensity of rivalry in the market. The market is growing with a prominent growth rate and likely to provide opportunities for major players to expand their geographical boundaries which will initiate cutthroat competition between major players to capture maximum market share in the emerging markets. Players are engaged in developing a process to lower their development cost to increase profitability and to overcome the competition. Moreover, they are also developing advanced platforms for differentiating their brand from their competitors.
